Could Changing the THC/CBD Ratio in Cannabis Reduce Its Harms?
A commentary argued that public health interventions should target specific drug-related harms rather than prohibit use, suggesting that reducing THC and increasing CBD content in cannabis could lower psychosis and addiction risk.
Quick Facts
What This Study Found
This commentary made two specific harm-reduction proposals:
For alcohol: adding dissolved oxygen could reduce accident risk and liver damage.
For cannabis: strong evidence indicated that reducing THC content and increasing CBD content could reduce the risk of psychosis and addiction associated with cannabis use.
The author argued that public health interventions should focus on reducing concrete harms rather than making moral judgments about which human experiences should or should not be enhanced through substance use.
The central proposition was that responsible regulation should not be limited to preventing or reducing use, but should include strategies to reduce the burden of illness associated with substance use.
Key Numbers
Two substances discussed: alcohol (dissolved oxygen proposal) and cannabis (THC reduction, CBD increase). Evidence cited for CBD reducing psychosis and addiction risk.
How They Did This
Commentary/editorial presenting evidence-based harm reduction proposals for alcohol and cannabis, arguing for regulatory approaches focused on specific harm reduction.
Why This Research Matters
This commentary articulated a regulatory philosophy that has gained traction: rather than debating whether people should use cannabis, focus on making the available products less harmful through compositional standards.
The Bigger Picture
As cannabis legalization has expanded, the idea of regulating cannabis composition (THC limits, minimum CBD requirements) has become increasingly relevant. This 2010 commentary was ahead of its time in proposing evidence-based product standards.
What This Study Doesn't Tell Us
Commentary piece rather than original research. The practical feasibility of regulating cannabis composition was not fully addressed. The dissolved oxygen/alcohol proposal had limited evidence.
Questions This Raises
- ?Should legal cannabis markets mandate maximum THC or minimum CBD levels?
- ?Would consumers accept regulated composition products?
- ?Could compositional standards be enforced effectively?
Trust & Context
- Key Stat:
- Reducing THC and increasing CBD in cannabis could reduce psychosis and addiction risk
- Evidence Grade:
- Expert commentary informed by existing evidence. Proposes regulatory approaches rather than presenting new data.
- Study Age:
- Published in 2010. Cannabis potency regulation and CBD requirements have since become active policy discussions in many jurisdictions.
- Original Title:
- Enhancement drugs: are there limits to what we should enhance and why?
- Published In:
- BMC medicine, 8, 50 (2010)
- Authors:
- Hesse, Morten
- Database ID:
- RTHC-00421
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Could changing the THC/CBD ratio make cannabis safer?
Research supports this idea. Higher-THC, lower-CBD cannabis has been associated with greater psychosis risk and dependence. Products with balanced or higher CBD content appear to carry lower risk for these outcomes.
Why not just ban cannabis instead?
The author argued that prohibition has not prevented cannabis use and creates additional harms (criminalization, unregulated markets). Regulation that focuses on reducing specific harms through product composition could be more effective than prohibition.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBT-cannabis-recovery
- THC-potency-increase-over-time
- cannabis-harm-reduction-opioids-alcohol-replacement
- cannabis-legalization-effects-health-data
- cannabis-relapse-cycle-pattern
- cannabis-tolerance-break-guide
- cold-turkey-vs-taper-quit-weed
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- how-to-cut-back-on-weed-moderation
- how-to-quit-weed
- journaling-weed-withdrawal
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- microdosing-cannabis-benefits
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- safer-cannabis-use-guidelines
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- sober-october-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- tolerance-break-weed
- weed-for-opioid-withdrawal
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
- does-weed-expire-shelf-life-potency
- how-to-store-weed-fresh-temperature-light
- what-is-dabbing-what-does-it-do-body
- what-are-moon-rocks-why-strong
- cannabis-consumption-method-quiz-find-your-fit
- what-consumption-method-right-for-you-quiz
Cite This Study
https://rethinkthc.com/research/RTHC-00421APA
Hesse, Morten. (2010). Enhancement drugs: are there limits to what we should enhance and why?. BMC medicine, 8, 50. https://doi.org/10.1186/1741-7015-8-50
MLA
Hesse, Morten. "Enhancement drugs: are there limits to what we should enhance and why?." BMC medicine, 2010. https://doi.org/10.1186/1741-7015-8-50
RethinkTHC
RethinkTHC Research Database. "Enhancement drugs: are there limits to what we should enhanc..." RTHC-00421. Retrieved from https://rethinkthc.com/research/hesse-2010-enhancement-drugs-are-there
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.